Preferred Label : Pharmacogenomic Study;
NCIt related terms : PHARMACOGENOMIC;
NCIt definition : A study of identification and analysis of genomic variations that affect the efficacy
of a drug. Pharmacogenomic studies can potentially be predictive of an individual's
drug-response or adverse reactions or susceptibility to iatrogenic disorders, and
may also reveal new targets that can help in the design of new drugs.;
Alternative definition : CDISC: A study that identifies or assesses variations within the entire genome, including
DNA, RNA, or transcriptional elements, and its effects on drug response.;
Origin ID : C49661;
UMLS CUI : C1709519;
Automatic exact mappings (from CISMeF team)
- Semantic type(s)
- concept_is_in_subset
